	Diagnosis and Management of Chronic Lymphocytic Leukemia with TP53 Loss of Function in the Novel Agent Era. Blood Tam CS, Seymour JF, Blombery P. PMID: 42832420 [PubMed - as supplied by publisher]
	Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study. Blood Zhong X, Roberts KG, Wei H, Sun Z, Montefiori LE, Kumar A, Iacobucci I, Baviskar P, Gao Q, Pölönen P, Pruett-Miller SM, Schreiber RM, Chang TC, Zhang W, Lei S, Rampersaud E, Fan Y, Wu G, Mattison RJ, Zhang Y, Racevskis J, Lazarus HM, Rowe JM, Arber DA, Wieduwilt MJ, Abou Mourad Y, Shami PJ, Baer MR, Asch AS, O'Dwyer KM, Hall A, Liedtke M, Bergeron J, Wood BL, Pratz KW, Dinner SN, Frey NV, Gore SD, Bhatnagar B, Atallah EL, Uy GL, Jeyakumar D, Lin TL, Willman CL, Podoltsev NA, DeAngelo DJ, Patel S, Elliott MA, Advani AS, Tzachanis D, Vachhani P, Bhave RR, Sharon E, Little RF, Erba HP, Stone RM, Tallman MS, Yang JJ, Luger SM, Paietta E, Litzow MR, Mullighan CG. PMID: 42832396 [PubMed - as supplied by publisher]
	Feasibility of a prospective real-time monitoring system capturing real-world data from elderly patients with acute myeloid leukemia. ESMO Real World Data Digit Oncol Hermans SJF, Versluis J, Langhout S, van Werkhoven ED, Huls G, Chitu D, Westerweel PE, Fiets RB, Tick LW, Herbers AHE, Corsten MF, Breems DA, Nijhof IS, Cruijsen MJ, Sandberg Y, Davidis M, Koster A, van der Hem KG, van der Burg L, Baboe F, Posthuma EFM, Schade K, Berkx E, Dinmohamed AG, Huijgens PC, Cornelissen JJ. PMID: 42830877 [PubMed]
	Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL-2 Inhibitors. Cancer Med Schulze FJ, Shumilov E, Behringer A, Kerkhoff A, Eckhardt M, Bätker S, Maulhardt M, Lenz G, Pohlmann A. PMID: 42830438 [PubMed - indexed for MEDLINE]
	DETECTION OF HEPATITIS B AND C VIRAL INFECTION AMONG CHILDREN WITH ACUTE LEUKAEMIA. Georgian Med News Hussein S, Ahmed H, Ahmed A. PMID: 42830066 [PubMed - indexed for MEDLINE]
	Phase 1 dose escalation and expansion trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein SL-172154 (SIRPÎ±-Fc-CD40L) in patients with higher-risk myelodysplastic syndrome or acute myeloid leukemia. Cancer Daver NG, Zeidan AM, Stein AS, Zeidner JF, Maher K, Curran E, Bixby D, Chai-Ho W, Stahl M, Yee KWL, Stevens D, Ito S, Reynolds J, Medd P, Searle E, Sochacki A, Savoie ML, Green S, Kato K, Hernandez R, Metenou S, Ma B, Pandite L, Schreiber TH, Sallman DA. PMID: 42829896 [PubMed - indexed for MEDLINE]
	Mechanisms of Resistance to Targeted Therapy in Epidermal Growth Factor Receptor (EGFR)- and Anaplastic Lymphoma Kinase (ALK)-Mutated Non-small Cell Lung Cancer: Molecular Basis, Emerging Biomarkers, and Therapeutic Strategies. Cureus Dhillon S, Rathod H, Dhillon S. PMID: 42829510 [PubMed]
	The ferroptosis-cuproptosis crosstalk in hematological malignancies: multi-omics insights into gene-regulated cell death and emerging therapeutic opportunities. Apoptosis Antal S, Anshu T, Goswami PK, Kumar D, Choudhary N, Kadam AD. PMID: 42829391 [PubMed - indexed for MEDLINE]
	Systemic Retinoids in Cutaneous T-Cell Lymphoma: A Scoping Review of Clinical Use and Evidence Gaps. Dermatol Ther (Heidelb) Bui T, Niknejad K, Urbanski N, Fidan DG, Wolner Z, Rozati S. PMID: 42828677 [PubMed - as supplied by publisher]
	Machine learning-based early prediction of severe pneumonia risk in hospitalized leukemia patients: a dual-center retrospective cohort study. Front Cell Dev Biol Huang J, Wu Q, Zhang Y, Wang K, Wang Y, Tang C, Li C, Lin N. PMID: 42827898 [PubMed]
	All-Oral PI3KÎ´ and HDAC Inhibition with Parsaclisib Plus Chidamide and Step-Down Maintenance in Relapsed or Refractory Peripheral T-Cell Lymphoma: A Phase Ib Trial. MedComm (2020) Luo X, Yan Z, Fang W, Duan H, Zhang Q, Wang H, Yao S, Zhang J, Jin Y, Li W, Teng X, Zhang L, Liang L, Lin Q, Wang P, Si H, Miao J, Zhou W, Yao Z, He YW, Xia Q, Liu Y. PMID: 42827632 [PubMed]
	First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival. Leukemia U Niemann C, Munir T, Owen C, Follows G, Hernández-Rivas JÁ, Benjamini O, Janssens A, Levin MD, Robak T, Simkovic M, Voloshin S, Vorobyev V, Ysebaert L, Schuier N, Baeten K, Tran N, Levitan B, Kavanagh C, Kater AP. PMID: 42827117 [PubMed - as supplied by publisher]
	Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease. Leukemia Choi MY, Ghia EM, Siddiqi T, Barrientos JC, Tuscano J, Koff JL, Yazji S, Leslie LA, Isufi I, Lamanna N, Goldenberg A, Chung G, Subbiah S, Robinson JM, O'Neill S, Jamieson CHM, Breitmeyer JB, Wierda WG, Kipps TJ. PMID: 42827116 [PubMed - as supplied by publisher]
	Phase 1/2 study of favezelimab plus pembrolizumab in anti-PD-1-naive relapsed or refractory classical Hodgkin lymphoma. Blood Adv Johnson NA, Lavie D, Borchmann P, Gregory GP, Herrera AF, Minuk L, Vucinic V, Armand P, Avigdor A, Gasiorowski R, Herishanu Y, Keane C, Kuruvilla J, Marceu West R, Pillai PM, Marinello P, Timmerman JM. PMID: 42826707 [PubMed - as supplied by publisher]
	Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy. Neurology Mersali S, Chapelle R, Ribeiro M, Weiss N, Psimaras D, Le Guennec L, Birzu C, Hoang-Xuan K, Boussen I, Baron M, Morel V, Uzunov M, Friser V, Choquet S, Houillier C. PMID: 42826379 [PubMed - indexed for MEDLINE]
	Primary pulmonary mucosa-associated lymphoid tissue lymphoma presenting as a right hilar mass: A case report. Medicine (Baltimore) Fu L, Zeng T, Hong C, Zhang Y, Huang H. PMID: 42826325 [PubMed - indexed for MEDLINE]
	Angioimmunoblastic T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis initially misdiagnosed as classical Hodgkin lymphoma: A case report. Medicine (Baltimore) Li R, Chen Y, Liu X, Gao Y, Zhu N, Deng C, Li Y. PMID: 42826277 [PubMed - indexed for MEDLINE]
	Concurrent presentation of distinct extranodal and splenic marginal zone lymphomas. J Hematop Grevet JD, Zhang Y, Sadigh S, Kim AI. PMID: 42825886 [PubMed - indexed for MEDLINE]
	Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial. Blood Patel K, Shah GL, Schöder H, Ganesan N, Drill E, Hancock H, Davey T, Santarosa AM, Galasso N, Kumar A, Lahoud OB, Hamlin PA, Straus DJ, Owens CN, Caron PC, Intlekofer AM, Horwitz SM, Falchi L, Palomba ML, Noy A, Matasar MJ, Salles GA, Vardhana SA, Wills B, Yahalom J, Dogan A, Zelenetz AD, Wong P, Toyomura M, Michaud L, Sen F, Argyropoulos KV, Moskowitz CH, Moskowitz AJ. PMID: 42825495 [PubMed - as supplied by publisher]
	One cycle of nelarabine given after induction is well tolerated but does not improve outcome in adults with T-cell precursor acute lymphoblastic leukemia: Outcome data from the UKALL14 randomized-controlled trial. Hemasphere Rowntree CJ, Kirkwood AA, Farah N, Lawrie E, Marks DI, McMillan AK, Menne TF, Moorman AV, Patel B, Patrick P, Smith P, Alapi KZ, Wang L, Mansour MR, Fielding AK. PMID: 42824995 [PubMed]

Articles 1 - 20 / 170622

Page 1 of 8532



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy